In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana Benthamiana Plants
doi 10.20944/preprints201811.0383.v1
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2018
Authors
Publisher
MDPI AG